CENTER CITY (WPVI) -- Jefferson University Hospital's Sidney Kimmel Cancer Center will begin tests soon on a new type of COVID-19 drug. It's based on disease-fighting T-cells, drawn from healthy ...
A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
In an interview with Medical News Today, James Hindley, Ph.D., from Indoor Biotechnologies explains how his company is developing a new T cell test during the COVID-19 pandemic. He also reveals why ...
Virax Biolabs Group Limited (NASDAQ:VRAX) announced on Tuesday that it had signed a Research Services Agreement (RSA) with Emory University's Center for the Advancement of Diagnostics for a Just ...
LONDON, Dec. 21, 2023 /PRNewswire/ -- Virax Biolabs Group Limited (VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results